AI Swallowing Assessment
Voice-biomarker and deep-learning analysis to flag swallowing risk, routing clinical alerts to speech therapists on staff — not as a diagnostic device, but as an AI-assisted wellness tracker.
Coming Q1 2027 · TechUP-Funded · HKD 600K R&D Grant
The first Cantonese-first AI companion device that combines dysphagia assessment, swallowing therapy exercises, and care-home clinical reporting — in one dedicated hardware unit.
Three in four nursing-home residents with dysphagia are never formally assessed. Aspiration pneumonia from unmanaged dysphagia is one of the leading preventable killers of the elderly across Asia. No FDA-cleared commercial voice-biomarker device for home-based AI dysphagia screening exists as of 2026. No eldercare hardware product globally offers Cantonese as its primary interface language.
Voice-biomarker and deep-learning analysis to flag swallowing risk, routing clinical alerts to speech therapists on staff — not as a diagnostic device, but as an AI-assisted wellness tracker.
Designed from the ground up for Cantonese-speaking elderly in Hong Kong and the Greater Bay Area. Zero existing competitors offer Cantonese as a primary eldercare AI interface.
Weekly dysphagia trend reports delivered to care-home speech therapists and nurses, creating a longitudinal clinical data layer no other device provides.
AI detects swallowing risk, recommends texture modification, SeniorDeli fulfills the food order, compliance is tracked, clinician receives a progress report.
LinguaLeap is built on a Raspberry Pi 5 platform (BOM ~USD 350) with a custom AI inference stack trained on Cantonese speech and swallowing biomarkers. Software runs on the same unified Supabase backend as the SeniorDeli platform and the nurse dashboard.
Dec 2025
TechUP Y06 grant awarded — HKD 600,000
Q1 2026
Hardware prototype (Pi 5) + AI inference stack
Q2-Q3 2026
RCHE pilot partnerships (2-3 Hong Kong care homes)
Q4 2026
HKMD Class I registration; clinical outcome data collection
Q1 2027
Clinical edition launch to RCHE partners
2027
FDA Breakthrough Device program — application in preparation; HKMD Class II application
Be the first to hear about LinguaLeap's Q1 2027 launch. We are prioritising care-home partners, speech therapists, and family caregivers in Hong Kong and the Greater Bay Area.
Or email us directly at lingualeap@seniordeli.com
This tool provides general food texture education and IDDSI self-check support only. It is not a clinical assessment, diagnostic device, or medical advice. Consult a qualified speech-language pathologist or dietitian for medical concerns.